Citius Pharmaceuticals Inc - Warrants(02/08/2022)
CTXRW - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.77M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $3.77 Million |
|---|---|
| Enterprise Value | $-6,059,367.00 |
| Earnings per Share | $-3.38 |
| Beta | -2.77 |
| Outstanding Shares | 26,169,589 |
Return
| Return on Equity | -86.14% |
|---|---|
| Return on Assets | -40.34% |
| Return on Invested Capital | -65.91% |
Valuation & Multiples
| P/E Ratio | -0.25 |
|---|---|
| PEG | -0.7 |
| Price to Sales | - |
| Price to Book Ratio | 0.07 |
| Enterprise Value to Revenue | 0.64 |
| Enterprise Value to EBIT | -0.08 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 1.58 |
| Debt to Equity | 0.11 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 14, 2026
EPS Estimate
$0.03
Consensus analyst estimateRevenue Estimate
$12.52 M
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Citius Pharmaceuticals Inc
10 employees
CEO: Myron Holubiak
